NYSE:BMY   Bristol-Myers Squibb Company
Healthy pipeline.

Sitting at 3.32% yield and 8.62 P/E (norm is 18.65 and 5Y norm is 11.17) with earnings growth rate approx. 6.18% since 2000 but has increased to 15-16% if you look at the 10Y and 5Y norms.

Estimates are for about 4-6% the next 2 years.

A+ Credit Rating
48LT Debt to Cap

PT $96 by 2023 using a 7% earnings growth rate and 12 P/E

HUGE saucer pattern -- technically.
Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.